Cytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activity

Abstract Effective treatment of acute myeloid leukemia (AML) remains an urgent unmet need. Adoptive transfer of cytotoxic T cells (CTLs) against leukemia-associated antigen (LAA) has strong potential to improve AML treatment. However, the clinical translation of this therapeutic modality is hindered...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Chenchen Zhao, Bei Jia, Yixing Jiang, Hiroko Shike, Charyguly Annageldiyev, Joseph Cioccio, Kentaro Minagawa, Shin Mineishi, WChristopher Ehmann, Todd D. Schell, Hua Cheng, Hong Zheng
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Springer 2025-02-01
coleção:	Cancer Immunology, Immunotherapy
Assuntos:	AML Post-transplant relapse Cytotoxic lymphocytes Dendritic cell
Acesso em linha:	https://doi.org/10.1007/s00262-025-03971-y
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!